WASHINGTON DC (April 28, 2020) — On April 27, the US Food and Drug Administration provided an update on its efforts to ensure the availability of alcohol-based sanitizer to help meet the demand for hand-sanitizer during the COVID-19 pandemic. As a result of the agency’s significant flexibility, more than 1,500 additional manufacturers have registered with the agency to produce hand sanitizer.

WASHINGTON DC (April 22, 2020) — The US Food and Drug Administration has authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued the emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test to permit testing of samples self-collected by patients at home using LabCorp’s Pixel by LabCorp COVID-19 Test home collection kit.

WASHINGTON DC (April 16, 2020) — As part of the all-of-America approach to fighting the COVID-19 pandemic, the US Food and Drug Administration has been working with partners across the US government, academia, and industry to expedite the development and availability of critical medical products to treat this novel virus.

WASHINGTON DC (April 15, 2020) — The COVID-19 pandemic has created challenges in our everyday lives. As we each do our part to help slow the spread of coronavirus disease, we look to the helpers all around us and wonder if we, too, could do more.

Here are some ways you and your family can help.